Financials
Income statement
| Fiscal date | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
|---|---|---|---|---|
| Total reported revenue | 13.1B | 16.4B | 14.1B | 13.5B |
| Cost of revenue | 9.2B | 11.4B | 9.6B | 9.4B |
| Gross profit | 3.9B | 5.0B | 4.4B | 4.1B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 2.5B | 3.1B | 2.7B | 2.7B |
| Other operating expenses | — | — | — | — |
| Operating income | 1.3B | 1.8B | 1.7B | 1.4B |
| Non operating interest income | ||||
| Income | 48M | 59M | 63M | 66M |
| Expense | 18M | 17M | 20M | 20M |
| Other income expense | — | — | — | — |
| Pretax income | 1.3B | 1.9B | 1.7B | 1.5B |
| Tax provision | 310M | 491M | 439M | 369M |
| Net income | 1.0B | 1.4B | 1.3B | 1.1B |
| Basic EPS | 0.9 | 1.2 | 1.1 | 1.0 |
| Diluted EPS | 0.9 | 1.2 | 1.1 | 1.0 |
| Basic average shares | 1.1B | 1.1B | 1.1B | 1.1B |
| Diluted average shares | 1.1B | 1.1B | 1.1B | 1.1B |
| EBITDA | 1.7B | 2.2B | 2.0B | 1.8B |
| Net income from continuing op. | 1.0B | 1.4B | 1.3B | 1.1B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |